-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Cellebrite DI (NASDAQ:CLBT) Stock Price Up 1.2%
Cellebrite DI (NASDAQ:CLBT) Stock Price Up 1.2%
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) rose 1.2% during trading on Friday . The stock traded as high as $4.18 and last traded at $4.18. Approximately 9,282 shares were traded during trading, a decline of 94% from the average daily volume of 152,588 shares. The stock had previously closed at $4.13.
Wall Street Analyst Weigh In
CLBT has been the subject of several analyst reports. Needham & Company LLC upped their target price on Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a report on Thursday, August 11th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. William Blair downgraded Cellebrite DI from an "outperform" rating to a "market perform" rating in a research note on Friday, August 12th. Finally, Bank of America downgraded Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $6.50 to $6.00 in a research note on Friday, August 12th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $9.71.
Get Cellebrite DI alerts:Cellebrite DI Price Performance
The stock has a market cap of $810.72 million, a price-to-earnings ratio of 5.81, a P/E/G ratio of 9.78 and a beta of 0.87. The business has a fifty day moving average of $5.00 and a 200 day moving average of $5.33.
Institutional Trading of Cellebrite DI
Several large investors have recently added to or reduced their stakes in CLBT. Phoenix Holdings Ltd. grew its position in Cellebrite DI by 303.6% in the first quarter. Phoenix Holdings Ltd. now owns 2,296,345 shares of the company's stock worth $14,706,000 after acquiring an additional 1,727,379 shares in the last quarter. Greenhaven Road Investment Management L.P. bought a new stake in Cellebrite DI in the fourth quarter worth approximately $9,453,000. Blair William & Co. IL grew its position in Cellebrite DI by 3,021.1% in the first quarter. Blair William & Co. IL now owns 523,978 shares of the company's stock worth $3,353,000 after acquiring an additional 507,190 shares in the last quarter. ARK Investment Management LLC bought a new stake in Cellebrite DI in the first quarter worth approximately $2,621,000. Finally, CIBC Asset Management Inc grew its position in Cellebrite DI by 5.8% in the first quarter. CIBC Asset Management Inc now owns 2,352,733 shares of the company's stock worth $15,057,000 after acquiring an additional 129,244 shares in the last quarter. 20.41% of the stock is owned by institutional investors.About Cellebrite DI
(Get Rating)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Read More
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) rose 1.2% during trading on Friday . The stock traded as high as $4.18 and last traded at $4.18. Approximately 9,282 shares were traded during trading, a decline of 94% from the average daily volume of 152,588 shares. The stock had previously closed at $4.13.
凱樂布萊特DI有限公司(納斯達克代碼：CLBT-GET評級)在週五的交易中上漲1.2%。該股一度漲至4.18美元，最後報4.18美元。當日成交量約為9,282股，較152,588股的日均成交量下降94%。該股此前收盤價為4.13美元。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
CLBT has been the subject of several analyst reports. Needham & Company LLC upped their target price on Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a report on Thursday, August 11th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. William Blair downgraded Cellebrite DI from an "outperform" rating to a "market perform" rating in a research note on Friday, August 12th. Finally, Bank of America downgraded Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $6.50 to $6.00 in a research note on Friday, August 12th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $9.71.
CLBT一直是幾份分析師報告的主題。Needham&Company LLC在8月11日週四的一份報告中將Cellebrite DI的目標價從6.00美元上調至6.50美元，並給予該公司“買入”評級。考恩將Cellebrite DI的目標價從13.00美元下調至10.00美元，並在8月12日(星期五)的一份研究報告中為該公司設定了“跑贏大盤”的評級。考恩將Cellebrite DI的目標價從13.00美元下調至10.00美元，並在8月12日(星期五)的一份研究報告中為該公司設定了“跑贏大盤”的評級。在8月12日星期五的一份研究報告中，威廉·布萊爾將Cellebrite DI的評級從“跑贏大盤”下調至“市場表現”。最後，在8月12日星期五的一份研究報告中，美國銀行將Cellebrite DI的評級從買入下調至中性，並將該股的目標價從6.50美元下調至6.00美元。兩名分析師對該股的評級為持有，六名分析師對該股的評級為買入。根據MarketBeat的數據，該公司目前的普遍評級為“適度買入”，平均目標價為9.71美元。
Cellebrite DI Price Performance
Cellebrite DI性價比
The stock has a market cap of $810.72 million, a price-to-earnings ratio of 5.81, a P/E/G ratio of 9.78 and a beta of 0.87. The business has a fifty day moving average of $5.00 and a 200 day moving average of $5.33.
該股市值為8.1072億美元，市盈率為5.81倍，市盈率為9.78倍，貝塔係數為0.87。該業務的50日移動均線切入位在5.00美元，200日移動均線切入位在5.33美元。
Institutional Trading of Cellebrite DI
凱勒布利特DI的機構交易
About Cellebrite DI
關於Cellebrite DI
(Get Rating)
(獲取評級)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite DI Ltd.為法律批准的調查開發解決方案。其DI平臺允許用户在整個調查生命週期中收集、審查、分析和管理與法律批准的調查有關的數字數據，並在各種案件中使用解決方案，包括剝削兒童、兇殺、反恐、邊境控制、性犯罪、人口販運、企業安全、知識產權盜竊和民事訴訟。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 免費獲取StockNews.com關於Cellebrite DI(CLBT)的研究報告
- 華爾街對Datadog的熱情會帶來巨大的收益嗎？
- MarketBeat：回顧一週9/19-9/23
- 為什麼特斯拉的股票保持彈性？
- 需要關注的2只半導體類股走勢逆轉
- 小盤股的裁員是樓市的晴雨表嗎？
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
接受《凱爾布賴特DI日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cellebrite DI和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧